NYSE:AMAM
Delisted

Ambrx Biopharma Stock Signals

etoro logo Buy AMAM
*Your capital is at risk
$28.00
+0 (+0%)
At Close: Jun 05, 2024

Latest Data & Signals Issued

Below are some of the latest signals issued for Ambrx Biopharma Inc.

General

Signal Type Signal Value Data
Score 0.000 129 days ( -138.91 %
Last Price $28.00 0 %
Performance History
7 Days
$28.00 $28.00
0%
30 Days
$28.00 $28.00
0%
12 Mos
$12.90 $28.00
117.05%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $28.00 - $28.00
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jun 04, 2024 - 2 days
RSI Short Pivot Signal Sell Very Low Mar 18, 2024 - 55 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 74.41
Signal Type Signal Value Importance Data
Trend - 12 mos 128.29 % Very High Width: 81.66 %
Pred. range - 12 mos $45.61 - $82.86 High 62.91 % - 195.93 %
Short MA 12 mos Buy Very High Feb 21, 2024 - 73 days
Long MA 12 mos Buy Very High Nov 30, 2023 - 128 days
Short/Long MA 12 mos Buy Very High Dec 18, 2023 - 116 days
Pivot Long Sell Low Jan 11, 2024 - 100 days
RSI Long Pivot Signal Sell Low Mar 27, 2024 - 48 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT AMBRX BIOPHARMA INC.
Ambrx Biopharma
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gastric/gastroesophageal junction cancer, and other solid tumors, including ongoing Phase 2/3 clinical tri...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE